Novavax, Inc. reported 3Q25 EPS loss & declining revenue, but beat revenue expectations & reaffirmed its FY25 guidance. Read ...
Adjusted Total Revenue is a non-GAAP financial measure. Adjusted Total Revenue is total revenue excluding Sanofi Supply Sales, Sanofi Royalties and Sanofi Influenza-COVID-19 Combination and Matrix-M ...
Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...
Shah Capital frustrated with Novavax's weak COVID-19 vaccine sales Hedge fund increases stake to 8.3%, urges sale to large pharma Novavax's COVID vaccine sales lag behind competitors Nov 13 (Reuters) ...
On Wednesday, 19 November 2025, Novavax (NASDAQ:NVAX) presented its strategic vision at the Jefferies London Healthcare Conference 2025. The company outlined a significant transition from ...
The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
(RTTNews) - Novavax Inc. (NVAX) released Loss for its third quarter that increased from the same period last year and missed the Street estimates. The company's bottom line totaled -$202.379 million, ...
Shares of Novavax Inc. NVAX slipped 3.23% to $7.20 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.68% to ...
Shares of Novavax Inc. NVAX slid 1.30% to $7.59 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.90% to 23,053.99 ...
Rick Warren is a Senior Features Editor from the United States. He is a lifelong gamer and comics fan who loves writing about everything in nerd culture, and absolutely adores Trophy hunting on PSN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results